SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that Medicare reimbursement for CorMedixs DefenCath could fall sharply in 2027 has fueled a steep selloff and concern about future pricing and sales. Traders dispute how conclusive DaVitas estimate is, pointing to CMSs finalized payment rate and arguing the outlook depends on quarterly calculations and DefenCath uptake.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

FDA approval of Inovios competing RRP treatment has put Precigens PAPZIMEOS under scrutiny, with traders debating whether the new option will erode its market position. Some fear stronger competition, while others point to Precigens first-mover and full-approval advantages and question Inovios ability to commercialize its drug.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons stronger-than-expected third-quarter results, supported by Eylea HD and Dupixent-related collaboration revenue, are driving a sharp breakout to multiyear highs. Traders are broadly bullish on the results and follow-through, while some question whether the gains will hold.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is drawing attention after Brazil approved its Valaris merger, which traders see as a step toward closing the deal, alongside recent offshore contract wins and higher day-rate expectations. Bulls anticipate improved scale and a potential short squeeze, while skeptics point to merger-related dilution, debt and the upcoming earnings report.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopifys integration with Metas Muse AI agent, which can route purchases through Shop Pay, has fueled discussion about whether agentic commerce will expand Shopifys role in online shopping or threaten traditional storefronts. Traders are also debating the stocks sharp, volatile pullback, with some looking ahead to earnings and others concerned about valuation and whether AI-related growth will translate into revenue.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,942,077.7905448. The last known price of Zcash is 1,263.32437248 USD and is up 2.82 over the last 24 hours. It is currently trading on 668 active market(s) with $1,115,981,976.30 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp rebound and resilience amid broader crypto weakness and Binance hack fears have traders highlighting its privacy features and speculating about a safe-haven shift into ZEC; some also point to the upcoming NU7 upgrade. Others view the rally as overextended and expect further declines.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

A stronger-than-expected quarterly report and higher full-year revenue outlook, powered by demand for Mounjaro and Zepbound, have fueled LLYs rally and record highs. Traders are largely positive and cite analyst upgrades, while some question the valuation and point to trimmed profit guidance tied to acquisition-related research charges.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A rally to a fresh 52-week high ahead of an expected quarterly report has traders focused on BRIUMVI growth and whether results can justify the run; some expect an earnings-driven move, while others warn the stock may be priced for a beat. Buyout speculation and possible short covering are also fueling bullish chatter, but no deal is confirmed and the earnings timing remains uncertain.

BankrCoin (BNKR) is a cryptocurrency and operates on the Base platform. BankrCoin has a current supply of 100,000,000,000 with 99,389,999,999.99966667 in circulation. The last known price of BankrCoin is 0.00029512 USD and is up 9.48 over the last 24 hours. It is currently trading on 84 active market(s) with $2,292,823.67 traded over the last 24 hours. More information can be found at https://warpcast.com/bankr.

BankrCoin

Traders are focused on Bankrs expanding AI-agent infrastructure and ecosystem integrations, alongside claims of protocol revenue, staking rewards and token buybacks that could support BNKR demand. Sentiment is largely bullish and accumulation-oriented, though some traders question whether the sharp moves are sustainable or speculative.

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxons quarterly results beat expectations, with record refining performance benefiting from tight diesel supplies amid geopolitical disruptions. Traders are broadly positive on the refining-led strength and shareholder returns, while some question whether the unusually strong margins can last.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What's Going on With Cue Biopharma Stock on Monday?

Cue Biopharma reports Phase 2 CUE-221 trial results in chronic hives, showing strong efficacy and favorable safety.read more...

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers

Greenland Mines (NASDAQ:GRML) stock rose 108.1% to $5.93 during Monday's pre-market session. The market value of their outstanding shares is at $9.0 million.
Cue Biopharma (NASDAQ:CUE) stock moved upwardsread more...

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Cue Biopharma, Inc. (NASDAQ: CUE)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Cue Biopharma, Inc. (NASDAQ: CUE) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Cue Biopharma, Inc. (NASDAQ: CUE) PR Newswire NEW YORK, Aug. 24, 2026 NEW YORK, Aug. 24, 2026...

Small Cap Stocks To Follow Now - May 3rd

Inflection Point Acquisition Corp. II, Direxion Daily MU Bull 2X Shares, and Cue Biopharma are the three Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of publicly traded companies with relatively small market capitalizationstypically ro...

Cue Biopharma (NASDAQ:CUE) Downgraded to Buy Rating by Wall Street Zen

Wall Street Zen lowered Cue Biopharma from a "strong-buy" rating to a "buy" rating in a research note on Sunday...

Small Cap Stocks To Follow Now - May 2nd

Inflection Point Acquisition Corp. II, Direxion Daily MU Bull 2X Shares, Cue Biopharma, Esperion Therapeutics, and Akanda are the five Small Cap stocks to watch today, according to MarketBeat's stock...

Top Small Cap Stocks To Add to Your Watchlist - May 1st

This Market Is Moving Fast

The market is sending a clear signal: capital is flowing aggressively into platforms that can scale innovation, whether that’s next-generation immunotherapy, AI-driven digital ecosystems, or entirely new infrastructure for energy and materials. This week’s developments, from fresh biotech funding to explosive user growth in social platforms and bold pivots into clean energy, highlight a broader theme: investors are rewarding companies that are either accelerating commercialization or positioning themselves at critical bottlenecks in emerging industries. $CUE, $RDDT, $SOBR, $KBLB, $WTO, $AKAN

Nasdaq, S&P 500 Futures Take A Breather Near Highs: Why AAPL, META, RDDT, RBLX, CUE Are Keeping Traders Engaged Today

Equity

Data from Stocktwits shows that retail traders are bullish on SPY and QQQ again.


Cue Biopharma Stock Surges Over 65% Overnight: Why Is It Moving?

Cue Biopharma Inc. shares surged 67.57% after announcing a $30M financing, anti-IgE antibody license, and new CEO.read more...

• Reported GAAP EPS of -$24.14 down -804.12% YoY
• Reported revenue of $7.88M up 166.66% YoY
• Cue Biopharma, Inc. believes that its cash and cash equivalents on hand as of June 30, 2026, along with the net proceeds from the July 2026 private placement, will be sufficient.

Cue Biopharma, Inc. faces significant risks including a history of operating losses, dependence on successful clinical development of drug candidates, and potential limitations in accessing clinical trial data from China.

Cue Biopharma, Inc. is advancing a portfolio of transformative therapies using its Immuno-STAT platform and has secured significant additional capital to fund its research and development and ongoing operations.

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in advancing a portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its pipeline includes CUE-221, a novel anti-IgE antibody with a dual mechanism of action, and CUE-401, designed to regulate inflammation and drive Treg-mediated tolerance. The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Cue Biopharma Inc

Bearish Sentiment

<ul class="summary-bullets"><li>Early market action suggests a pause after a blockbuster April rally led by AI and mega-cap tech.</li><li>The White House argued that a recent ceasefire resets the 60-day War Powers clock, while Iran threatened ‘painful strikes’ if U.S. attacks resume.&nbsp;&nbsp;</li><li>Berkshire Hathaway's annual meeting kicks off in Omaha today.</li></ul>U.S. stock futures were subdued early Friday as investors took a breather following a historic April, the best month for markets since 2020. Traders are watching for developments in the Middle East amid a critical deadline for the Trump administration. The White House argued that a recent ceasefire resets the 60-day War Powers clock, while Iran threatened ‘painful strikes’ if U.S. attacks resume.&nbsp;&nbsp;As of 4:00 a.m. ET on Friday: Dow, S&amp;P 500 and Nasdaq futures were flat, while Russell 2000 futures declined 0.1%.Retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, an exchange-traded fund that tracks the S&amp;P 500 Index, has moved to ‘extremely bullish’ from ‘bullish’ territory, while the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> ETF, which tracks the Nasdaq-100 Index, has stayed in the ‘bullish’ territory after markets closed out April at record highs.&nbsp;Trending Stocks To WatchApple (AAPL):&nbsp;Stock rose 3% in early premarket trade after beating Q2 estimates and forecasting strong revenue growth despite supply constraints.&nbsp;Reddit (RDDT) is also seeing an post-earnings rally, surging 16% in early premarket trading.Rivian Automotive (RIVN)&nbsp;slipped 4% in early premarket trading as investors reacted to a lack of fresh details on the upcoming R2 SUV. While Nio Inc (NIO) slipped 3% after the Chinese EV maker reported a decline in April deliveries,&nbsp; casting a shadow over its SUV launch push.Roblox (RBLX):&nbsp;Tanked 22% after slashing its full-year bookings guidance well below analyst projections.&nbsp;Meta Inc (META):&nbsp;Investors will be tracking the ongoing child safety litigation in New Mexico, though ARK Invest added 47k shares on Thursday.&nbsp;Veeva Systems (VEEV): It is set to join the S&amp;P 500 on May 7, replacing Coterra Energy following its acquisition by Devon Energy. Michael Burry called it ‘undervalued’.Cue Biopharma (CUE)&nbsp;continued its upmove, rising another 40% in early premarket trading after it announced a $30 million private investment in public equity financing, an exclusive Phase 2 anti-IgE antibody license, and a CEO appointment.&nbsp;Other tickers trending on Stocktwits&nbsp;at the time of writing included Akanda Corp (AKAN), Sandisk Corp (SNDK), Eli Lilly (LLY), and Atlassian Corp (TEAM).Berkshire Hathaway’s annual meeting kicks off in Omaha today.&nbsp;Other Catalysts To WatchOn the economic front, traders will be watching the release of April manufacturing data.&nbsp;On earnings radar, watch out for quarterly reports from Exxon Mobil (XOM), Chevron (CVX), Aon (AON), Colgate-Palmolive (CL), Estee Lauder (EL), Church &amp; Dwight (CHD), AutoNation (AN), Terex (TEX), Lear (LEA), Cinemark (CNK), and WisdomTree (WT) before the bell today. For updates and corrections, email newsroom[at]stocktwits[dot]com

Data from Stocktwits shows that retail traders are bullish on SPY and QQQ again.

Nasdaq, S&P 500 Futures Pause After Best April Since 2020: Why AAPL, META, RDDT, RBLX, CUE Are In Focus

Apple Inc

Roblox Corp.

Reddit Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

$CUE just got update from my sources & from 1-10 it’s a bona fide 9.99‼️Positon ur selves to run w/the Bulls…data should be out no later than 2nd wk of November…good luck to all & get ready to boogie💥😎‼️

da printa

$CUE Small cap getting beat up. Awaiting cue data in next 30 days…buy dip(here) & sell the rip(?! …a lot higher;&, like it’s on fire 🔥;4REAL‼️

$CUE Biotech trading poorly last 2 weeks with rates moving up…data w/in 30-45 days ;perhaps sooner…remain confident & continue to buy@these level$$$!!! The proof will be forthcoming & w/a small # of outstanding shares & the largest shareholders(my source) controlling & owning a majority of the shares in the float(haven’t sold) it comes down to the irrefutable law of supply and demand!

$CUE Trades going thru at $21.71 and $20..95. Me thinks the criminals are sending out smoke signals they plan to crush it today.

Billy Peters

$CUE keep your eyes peeled! This stock is seeing an increase in volume!

$MI #momentum $FRGT #stockstotrade $AIXI #darkpoolai

DARKP00L

$CUE @InvestingDoc Can I please get your thoughts on CUE. Are you still bullish on the prospects for both the CUE-200 and 400 series, and te CEOs ability to deliver?

E S.

$CUE Now add $PN to the list trading $1.99 from $2.40 close. 
 
Now it looks like they plan on destroying The Chinas.

$CUE guys how do I get to know about these pennies before they rip? Any groups or anything that I can join?

Chartistry

$CUE Congrats on today and to those who knew this was coming. But pay attention now ladies. 
 
Tales of a Yo-Yo 
$31 a couple weeks ago.  
DOWN to $23's 
UP to $27's  
DOWN to $21's 
UP to $29 today 
 
Therefore?

Feed

News

Sentiment

Earnings

Fundamentals

Info

CUE Cue Biopharma Inc

Fundamentals

Latest CUE News